IP Library Granted Patent US 8,617,539
Granted Patent B2
US 8,617,539 · App. 13/418,948 · Granted Dec 31, 2013

Method of administration of platelet-rich plasma to treat an acute cardiac dysfunction

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,617,539
App. No.
13/418,948
Granted
Dec 31, 2013
Kind
B2
Abstract

Methods are described for using compositions containing platelet-rich plasma for the treatment of acute or chronic dysfunction of cardiac muscle. The method may employ a kit which includes a platelet-rich plasma composition and a pH adjusting agent and a catheter or syringe for delivery of the platelet-rich plasma composition to dysfunctional cardiac muscle. The kit may also include a syringe for withdrawing blood from a patient and a centrifuge device means to obtain platelet-rich plasma.

Claims (9)

1. A method of treating myocardial infarction in an individual comprising introducing an unactivated platelet-rich plasma composition via catheter or syringe into an area of dysfunctional cardiac muscle using a kit comprising:

a syringe for withdrawing blood from a patient;

a centrifuge device to obtain platelet-rich plasma;

a pH adjusting agent for the platelet-rich plasma to provide a platelet-rich composition having a pH of about 7.3 to 7.5; and

a catheter or syringe for delivery of the platelet-rich plasma composition to dysfunctional cardiac muscle, thereby treating myocardial infarction.

2. The method of claim 1 , wherein the pH adjusting agent is a bicarbonate buffer.

3. The method of claim 1 , wherein the introduction of the platelet-rich plasma is combined with an implantable device.

4. The method of claim 3 , wherein the implantable device is a stent.

5. The method of claim 1 , wherein the platelet-rich plasma composition comprises platelets obtained from the individual.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 6, 2021
From: MISHRA, ALLAN, DR.
To: BLUE ENGINE BIOLOGICS, LLC
Reel/Frame 056759/0943 →